L8.2 Ischemic heart disease Flashcards
How is coronary flow increased?
- Prolonged diastole → increases oxygen supply to the heart (coronary blood travels with diastole)
- Dilate coronary A
What is O2 demand dependent on?
- CO (workload)
- Preload (compliance)
- Afterload (resistance)
Definition of angina?
- Imbalance b/w o2 demand and supply
- Insufficient O2 to meet cardiac demand (due to lack of perfusion)
What are the 3 types of angina?
- Stable angina (classic)
- Chest pain with exertion/stress (demands met at rest)
- Associated with coronary A disease
- Variant angina (vasospastic)
- Coronary vasospasm at rest
- Mediator unknown
- Cannot treat well
- Unstable angina (crescendo)
- Angina at rest and with effort
- Potential for thrombus formation
Features of stable angina?
- Normally → dilation of A during exercise to increase flow to meet demands
- Angina occurs due to → already dilated at rest, no reserve dilation (due to low compliance) during exercise
- Increase O2 demands not met with increase BF

Aims of prevention for stable angina?
- Prevent attacks/relieve symptoms/prevent progression to MI
- Use drugs to increase O2 supply (hard → cannot increase arteriole size) & decrease O2 demand
Treating stable angina - by increase O2 supply
- Dilate coronary A
- Hard → may already be maximally dilated and has low compliance
- Reduce HR
- Longer diastole phase → coronary A have longer time to fill
Treating stable angina - by decreasing O2 demands
- Decrease CO (ß-adrenoceptor antagonists/Ca channel blockers/ivabradine(targets HR specifically))
- Decrease HR & SV
- Reduce preload (nitrates)
- Dilate veins/reduce venous return
- Reduce afterload (Ca channel blockers)
- Dilate arterioles, decrease resistance for heart to pump against
Mechanism of nitrates

Features of Nitrate
- Is usually a prodrug
- Mimicks endogenous procress (releasing NO)
- Guanylate cyclase → GTP into cGMP → MLC (myosin light chain) dephosphorylate form (unable to interact with actin) → vascular relaxation
- Nitrates can affect all vessels
- Predominant effect on the veins (decrease preload through vasodilations)
GTN
- short acting
- Routes of administration
- Undergo significant first pass metabolism (cannot be taken orally)
- Taken sublingually → to relieve acute attack
- Transdermal patch → for prophylaxis (prevention)
- I.v. → for emergency
- Unstable drug
- Cannot be stored in plastic (absorbed by plastic → decrease activity) and has to be stored in the dark
Isosorbide dinitrate
- longer acting
- Used orally for anticipation of effort or prophylaxtically
Nitrate SE
- Brief relaxation of gut/airways (not much clin significance)
- Postural hypotension (form venous pooling)
- Headache/flushing - from arterial dilations
- Small reflex tachycardia
- Usually used in combination with b-blockers or Ca channel blockers to minimise effect
Nitrate drug interactions
- Viagra is a phosphodiesterase inhibitor
- Phosphodiesterase breaks down cGMP
- Viagra + GTN → significant cGMP levels → too much venousdilation → may have fatally low VR
How does tolerance of nitrates develop
- Classic mechanism involves depletion of tissue thiols required for NO production from GTN
- Increase sensitivity of other constrictors (e.g. ANGII/A)
- Increase endothelial free radical production scavenging NO → reduce NO bioavailability
- Reduced acitivity of muscle mitochondrial enz → decrease NO production and increase free radicals
Tolerance develops with continuous use
How can tolerance with nitrates be prevented/attenuated?
- Need to maximise drug-free period (i.e. remove patch over night/period of non-exercise)
Ca channel blockers
- Used prophylactically
- Blocks Ca entry into the heart via L-type channel blocking
- Decrease HR → Increase supply
- Decrease CO/SV/HR → decreases demands
- Verapamil
- Nifedipine → selective for vasculature
- Leads to arterial dilation → reduce afterload and demands
Mechanism of Ca channel blockers
- *MLCK important for phosphorylation of MLC

SE of verapamil and nifedipine
Verapamil
- Constipation, flushing/headache/oedema (vasodilation)
- Bradycardia, AV block (acts on heart)
- NEVER taken with ß-blockers
Nifedipine
- Flushing/headache/oedema
- Hypotension (from arteriole dilations)
- Reflextachycardia (from hypotension)
B-blockers
- Acts to block the effect of SNS
- Receptors located on the SA, AV nodes → decrease HR/SV/CO
- Decrease workload of heart
- Increases O2 supply (from decrease HR)
- First-line therapy for prophylaxis
- Atenolol (selective ß1)
- Propranolol (non-selective)
Ivabradine
- Selective for reducing HR (doesn’t have cardio-depressive effects)
- Specific channels within SA node → I-f channel (which causes NA influx into cell)
- Inhibition leads to increase time taken for AP to reach threshold → reduces HR
- Disease-modifying by increasing O2 supply and decrease O2 (from decrease HR)
- Reduces risk of MI, and need for revascularisation
- No reduction if HR<70bpm

Ivabradine SE
- Channels also found in retina → brightness in visual fields
- Conduction abnormalities
- Long-term benefits/risks have been established
Overview of the treatment for stable angina

Treatment of variant angina
- Treatment: GTN (Short acting)
- To relieve vasospasm
- Prophylaxis with dihydropyridine Ca channel blocker (i.e. Nifedipine)
- Contra-indicated with ß-antagonist (potentially increase freq/severity of attacks)
Treatment for unstable angina
- Treatment same as classic angina
- Include aspirin for prevention of thrombosis
Risk factor reduction and prevention of heart diseases
Stop smoking
Increase physical activity & losing weight
Treat hypertension/dyslipidaemia/diabetes
When is revascularisation used
- When other treatments fails:
- Percutaneous coronary intervention
- Bypass graft